CTRI/2022/10/046562Not yet recruiting未知
Scientific evaluation for the effect of a unani Pharmacopoeial compound NUQU-E-UNNAB in Shara (Urticaria)
Department of Ilmul Advia0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Clinically diagnosed patients of CU according to the 2018 EAACI/GA2LEN/EDF/WAO guideline
- •2. Patients willing to sign consent form for the study.
Exclusion Criteria
- •1. Patients less than 14 and more than 60 years of age.
- •2. concomitant skin disease.
- •3. Patients suffering from any other systemic diseases, pregnant and lactating women.
- •4. unwillingness or inability to fulfil the protocol.
Investigators
Similar Trials
Recruiting
Phase 3
Clinical study to evaluate various biomarkers and effect of Unani formulations on these biomarkers in Vitiligo patientsCTRI/2015/10/006275Central Council for Research in Unani Medicine60
Completed
Phase 2
To study the effect of Unani drug in the treatment of patients with Chronic obstructive pulmonary disease.CTRI/2018/02/012180Jamia Hamdard60
Recruiting
Phase 4
To compare the effect of Phalatrikadi Kwath and Vrinda Triphaladi Kwath in obesityCTRI/2018/07/015075Chaudhary Brahm Prakash Ayurved Charak Sansthan
Not yet recruiting
Not Applicable
Additional Unani therapy for the patients of rheumatoid arthritis along with modern treatment.CTRI/2023/02/049413Department of Ilaj-bit-Tadbeer, Faculty of Unani Medicine
Not yet recruiting
Phase 2
Effect Of Phalatrikadi Churna Along With Dietery Modification And Musta Churna In The Patients Having Medodushti (Dyslipidemia)CTRI/2024/03/064569All India Institute Of Ayurveda